NEW YORK, Oct. 18, 2012 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

North America Diabetes Care Devices Market Outlook to 2018 - Glucose Monitoring and Insulin Delivery

http://www.reportlinker.com/p0739465/North-America-Diabetes-Care-Devices...

North America Diabetes Care Devices Market Outlook to 2018 - Glucose Monitoring and Insulin Delivery

Summary

GlobalData's new report, "North America Diabetes Care Devices Market Outlook to 2018 - Glucose Monitoring and Insulin Delivery" provides key market data on the North America Diabetes Care Devices market – United States and Canada. The report provides value (USD million) data for all the market categories – Glucose Monitoring and Insulin Delivery. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Scope

- Countries covered include United States and Canada.

- Market size and company share data for Diabetes Care Devices market categories – Glucose Monitoring and Insulin Delivery.

- Annualized market revenues (USD million) data for each of the market categories in each of the country. Data from 2004 to 2011, forecast forward for 7 years to 2018.

- 2011 company shares and distribution shares data for each of the market categories and countries.

- Global corporate-level profiles of key companies operating within the North America Diabetes Care Devices market.

- Key players covered include LifeScan, Inc., Medtronic, Inc., Bayer HealthCare AG, F. Hoffmann-La Roche Ltd., Abbott Laboratories, Becton, Dickinson and Company, Eli Lilly and Company, Animas Corporation, Novo Nordisk A/S, Insulet Corporation, Sanofi and Nipro Corporation.

Reasons to buy

- Develop business strategies by identifying the key market categories and segments poised for strong growth.

- Develop market-entry and market expansion strategies.

- Design competition strategies by identifying who-stands-where in the North America Diabetes Care Devices competitive landscape.

- Develop capital investment strategies by identifying the key market segments expected to register strong growth in the near future.

- What are the key distribution channels and what's the most preferred mode of product distribution – Identify, understand and capitalize.

1 Table of Contents

1 Table of Contents 2

1.1 List of Tables 7

1.2 List of Figures 8

2 Introduction 9

2.1 What is This Report About? 9

3 Diabetes Care Devices in North America 10

3.1 Diabetes Care Devices Cross Country Comparison, Revenue ($m), USD Constant, 2004-2018 10

3.2 Diabetes Care Devices, North America, Overall Revenue ($m), USD Constant, 2004-2018 11

3.3 Diabetes Care Devices, North America, Company share (2010-2011) 16

4 Diabetes Care Devices In United States 18

4.1 Diabetes Care Devices, United States, Overall Revenue ($m), USD Constant, 2004-2018 18

4.2 Diabetes Care Devices, United States, Distribution Share (2010-2011) 23

4.2.1 Glucose Monitoring, United States, Distribution Share (2010-2011) 23

4.2.2 Insulin Delivery, United States, Distribution Share (2010-2011) 23

4.3 Diabetes Care Devices, United States, Company Share (2010-2011) 24

4.3.1 Diabetes Care Devices, United States, Company Share (2010-2011) 24

4.3.2 Glucose Monitoring, United States, Company Share (2010-2011) 26

4.3.3 Insulin Delivery, United States, Company Share (2010-2011) 28

5 Diabetes Care Devices In Canada 30

5.1 Diabetes Care Devices, Canada, Overall Revenue ($m), USD Constant, 2004-2018 30

5.2 Diabetes Care Devices, Canada, Distribution Share (2010-2011) 35

5.2.1 Glucose Monitoring, Canada, Distribution Share (2010-2011) 35

5.2.2 Insulin Delivery, Canada, Distribution Share (2010-2011) 35

5.3 Diabetes Care Devices, Canada, Company Share (2010-2011) 36

5.3.1 Diabetes Care Devices, Canada, Company Share (2010-2011) 36

5.3.2 Glucose Monitoring, Canada, Company Share (2010-2011) 38

5.3.3 Insulin Delivery, Canada, Company Share (2010-2011) 40

6 Overview of Key Companies in North America Diabetes Care Devices Market 42

6.1 LifeScan, Inc. 42

6.1.1 Company Overview 42

6.1.2 Share in the North America Diabetes Care Devices Market 42

6.2 Medtronic, Inc. 43

6.2.1 Company Overview 43

6.2.2 Share in the North America Diabetes Care Devices Market 43

6.3 Bayer HealthCare AG 44

6.3.1 Company Overview 44

6.3.2 Share in the North America Diabetes Care Devices Market 44

6.4 F. Hoffmann-La Roche Ltd. 45

6.4.1 Company Overview 45

6.4.2 Share in the North America Diabetes Care Devices Market 45

6.5 Abbott Laboratories 46

6.5.1 Company Overview 46

6.5.2 Share in the North America Diabetes Care Devices Market 46

6.6 Becton, Dickinson and Company 47

6.6.1 Company Overview 47

6.6.2 Share in the North America Diabetes Care Devices Market 47

6.7 Eli Lilly and Company 48

6.7.1 Company Overview 48

6.8 Novo Nordisk A/S 48

6.8.1 Company Overview 48

6.9 Animas Corporation 48

6.9.1 Company Overview 48

6.10 Insulet Corporation 49

6.10.1 Company Overview 49

6.11 Sanofi 49

6.11.1 Company Overview 49

6.12 Nipro Corporation 50

6.12.1 Company Overview 50

6.13 ARKRAY, Inc. 50

6.13.1 Company Overview 50

7 Diabetes Care Devices Market Pipeline Products 51

8 Financial Deals Landscape 54

8.1 Acquisition 54

8.1.1 LifeScan Acquires Calibra Medical 54

8.1.2 Arriva Medical Acquires AmMed Direct For $23 Million 55

8.1.3 ActiveCare To Acquire 4G Biometrics, Healthcare Technology Company 56

8.1.4 DexCom Completes Acquisition Of SweetSpot Diabetes Care For Up To $8.5 Million 57

8.1.5 Arriva Medical Acquires Direct Diabetic Source 59

8.1.6 Perrigo Acquires CanAm Care, Distributor Of Diabetes Care Products, For $36 Million 60

8.1.7 Alere Acquires Arriva Medical From Palm Beach Capital For $83 Million 61

8.2 Partnerships 62

8.2.1 Nextgen Healthcare Enters Into Technology Integration Agreement With Nipro Diagnostics 62

8.2.2 Alere Enters Into Co-Development Agreement With AT&T 63

8.2.3 Telcare Enters Into Licensing Agreement With Diabetech For GlucoDynamix-ADMS 64

8.2.4 Tethys Bioscience Enters Into Technology Integration Agreement With Lose It 65

8.2.5 Juvenile Diabetes Research Foundation Extends Co-Development Agreement With Becton, Dickinson 66

8.2.6 Juvenile Diabetes Research Foundation Enters Into Co-Development Agreement With Helmsley Charitable Trust And Medtronic 67

8.2.7 Tandem Diabetes Enters Into Licensing Agreement With DexCom 68

8.2.8 Roche Diagnostics Enters Into Distribution Agreement With DexCom 69

8.2.9 Roche Diagnostics Enters Into Research And Development Agreement With DexCom 70

8.2.10 Pal Health Enters Into Distribution Agreement With Surefit For Xtremityone 71

9 Recent Developments 72

9.1 Strategy And Business Planning 72

9.1.1 Aug 28, 2012: Medtronic Opens Shanghai Innovation Center 72

9.1.2 Aug 09, 2012: Takeda Establishes Development Center In China 73

9.1.3 Jun 26, 2012: Roche To Shut New Jersey Site, Eliminate 1,000 Jobs 73

9.1.4 May 22, 2012: Greatbatch To Establish New Global Headquarters 74

9.1.5 Mar 21, 2012: HealthMed To Expand Portfolio Of Products Beyond Organ Transplantation 75

9.1.6 Feb 27, 2012: Greatbatch Announces Engagement To Advance Medical Device Strategy 75

9.1.7 Jan 26, 2012: Nipro Diagnostics Purchases New Building, Expands Fort Lauderdale Operations 76

9.1.8 Jan 19, 2012: BD And Mercy/ROi Collaborate To Improve Quality Of Care And Reduce Costs 76

9.1.9 Oct 19, 2011: Abbott To Separate Into Two Leading Companies In Diversified Medical Products And Research-Based Pharmaceuticals 77

9.1.10 Oct 13, 2011: Unisense Establishes US Headquarter 79

9.2 Legal and Regulatory 80

9.2.1 Jun 29, 2012: Sucampo Pharma Provides Update On Anticipated Arbitration Decision 80

9.2.2 May 30, 2012: Sucampo Announces Change In Date Of Anticipated Arbitration Decision In Dispute With Takeda 80

9.2.3 Apr 17, 2012: Sanmina-SCI Suzhou, China Facility Receives ISO 13485 Certification For Medical Devices 80

9.2.4 Mar 30, 2012: Medtronic Reaches Settlement Of Shareholder Class Action 81

9.2.5 Dec 23, 2011: Glancy Binkow Announces Class Action Lawsuit Against Hospira 81

9.2.6 Dec 13, 2011: Medtronic Reaches Settlement With US Department of Justice 81

9.2.7 Nov 22, 2011: Izard Nobel Announces Class Action Lawsuit Against Hospira 82

9.3 Government and Public Interest 83

9.3.1 Jun 28, 2012: American Diabetes Association Applauds US Supreme Court Decision To Uphold Affordable Care Act 83

9.3.2 Jun 15, 2012: American Diabetes Association Applauds Passage Of Connecticut House Bill 5348 83

9.3.3 Jun 15, 2012: American Diabetes Association Applauds Federal Funding For Diabetes Research And Prevention 84

9.3.4 Jun 15, 2012: OSA Is Associated With Diabetic Peripheral Neuropathy: Study 85

9.3.5 May 23, 2012: Beta Cell Imaging Could Help Spot Diabetes Earlier: Vanderbilt University 86

9.3.6 Mar 13, 2012: Researchers Identify Optimal Threshold For HbA1c Test For Prediabetes 87

9.3.7 Mar 01, 2012: Diabetes Research Institute Develops Revolutionary Oxygen-Generating Biomaterial To Enhance Islet Survival 88

9.3.8 Feb 13, 2012: Blood From Periodontal Disease Can Be Used To Screen For Diabetes: NYU Study 89

9.3.9 Jan 20, 2012: Researchers At Brown University Develops Biochip To Measures Glucose In Saliva 90

9.3.10 Jan 11, 2012: American Diabetes Association Applauds Revised US State Department Policy 91

9.3.11 Jan 03, 2012: Maternal Liver Grafts More Tolerable For Children With Rare Disease: UCSF 91

9.3.12 Oct 14, 2011: MannKind To Present At 18th Annual Newsmakers In BioTech Industry Conference 92

9.3.13 Sep 29, 2011: Research At UC Reveals Hormone Action That Could Lead To Treatments For Type 2 Diabetes 92

9.4 Product News 93

9.4.1 Oct 28, 2011: ARKRAY's GLUCOCARD Vital And 01 Blood Glucose Meters Are Listed On DoD Uniform Formulary 93

9.4.2 Jun 29, 2010: Medtronic Announces STAR 3 Trial Results Confirming MiniMed Paradigm REAL-Time System Achieves Better Glucose Control Than Daily Insulin Injections In Diabetic Patients 94

9.4.3 Jun 25, 2010: Medtronic Begins Enrollment In ASPIRE Pivotal Study Of MiniMed Paradigm x54 System 95

9.4.4 Mar 17, 2010: Medtronic Announces FDA Approval Of MiniMed Paradigm REAL-Time Revel System 95

10 Appendix 97

10.1 Definitions of Markets Covered in the Report 98

10.1.1 Diabetes Care Devices 98

10.2 Research Methodology 99

10.3 Secondary Research 99

10.4 Primary Research 100

10.5 Models 100

10.6 Forecasts 101

10.7 Expert Panels 101

10.8 GlobalData Consulting 101

10.9 Currency Conversion 102

10.10 Contact Us 102

10.11 Disclaimer 102

1.1 List of Tables

Table 1: Diabetes Care Devices, Cross Country Comparison, Revenue ($m),USD Constant, 2004-2018 10

Table 2: Diabetes Care Devices, North America, Overall Revenue ($m), USD Constant, 2004-2018 11

Table 3: Diabetes Care Devices, North America, Overall Revenue ($m), USD Constant, Historic, 2004-2011 13

Table 4: Diabetes Care Devices, North America, Overall Revenue ($m), USD Constant, Forecast, 2011-2018 15

Table 5: Diabetes Care Devices, North America, Company share by Revenue ($m), USD Constant, 2010-2011 17

Table 6: Diabetes Care Devices, United States, Overall Revenue ($m), USD Constant, 2004-2018 18

Table 7: Diabetes Care Devices, United States, Overall Revenue ($m), USD Constant, Historic, 2004-2011 20

Table 8: Diabetes Care Devices, United States, Overall Revenue ($m), USD Constant, Forecast, 2011-2018 22

Table 9: Glucose Monitoring, United States, Distribution Share by Revenue ($m), USD Constant, 2010-2011 23

Table 10: Insulin Delivery, United States, Distribution Share by Revenue ($m), USD Constant, 2010-2011 23

Table 11: Diabetes Care Devices, United States, Company Share, USD Constant, (2010-2011) 25

Table 12: Glucose Monitoring, United States, Company Share by Revenue ($m), USD Constant, 2010-2011 27

Table 13: Insulin Delivery, United States, Company Share by Revenue ($m), USD Constant, 2010-2011 29

Table 14: Diabetes Care Devices, Canada, Overall Revenue ($m), USD Constant, 2004-2018 30

Table 15: Diabetes Care Devices, Canada, Overall Revenue ($m), USD Constant, Historic, 2004-2011 32

Table 16: Diabetes Care Devices, Canada, Overall Revenue ($m), USD Constant, Forecast, 2011-2018 34

Table 17: Glucose Monitoring, Canada, Distribution Share by Revenue ($m), USD Constant, 2010-2011 35

Table 18: Insulin Delivery, Canada, Distribution Share by Revenue ($m), USD Constant, 2010-2011 35

Table 19: Diabetes Care Devices, Canada, Company Share, USD Constant, (2010-2011) 37

Table 20: Glucose Monitoring, Canada, Company Share by Revenue ($m), USD Constant, 2010-2011 39

Table 21: Insulin Delivery, Canada, Company Share by Revenue ($m), USD Constant, 2010-2011 41

Table 22: Diabetes Care DevicesMarket Pipeline Products 51

Table 23: LifeScan Acquires Calibra Medical 54

Table 24: Arriva Medical Acquires AmMed Direct For $23 Million 55

Table 25: ActiveCare To Acquire 4G Biometrics, Healthcare Technology Company 56

Table 26: DexCom Completes Acquisition Of SweetSpot Diabetes Care For Up To $8.5 Million 57

Table 27: Arriva Medical Acquires Direct Diabetic Source 59

Table 28: Perrigo Acquires CanAm Care, Distributor Of Diabetes Care Products, For $36 Million 60

Table 29: Alere Acquires Arriva Medical From Palm Beach Capital For $83 Million 61

Table 30: Nextgen Healthcare Enters Into Technology Integration Agreement With Nipro Diagnostics 62

Table 31: Alere Enters Into Co-Development Agreement With AT&T 63

Table 32: Telcare Enters Into Licensing Agreement With Diabetech For GlucoDynamix-ADMS 64

Table 33: Tethys Bioscience Enters Into Technology Integration Agreement With Lose It 65

Table 34: Juvenile Diabetes Research Foundation Extends Co-Development Agreement With Becton, Dickinson 66

Table 35: Juvenile Diabetes Research Foundation Enters Into Co-Development Agreement With Helmsley Charitable Trust And Medtronic 67

Table 36: Tandem Diabetes Enters Into Licensing Agreement With DexCom 68

Table 37: Roche Diagnostics Enters Into Distribution Agreement With DexCom 69

Table 38: Roche Diagnostics Enters Into Research And Development Agreement With DexCom 70

Table 39: Pal Health Enters Into Distribution Agreement With Surefit For Xtremityone 71

1.2 List of Figures

Figure 1: Diabetes Care Devices, Cross Country Comparison, Revenue ($m), USD Constant, 2004-2018 10

Figure 2: Diabetes Care Devices, North America, Overall Revenue ($m), USD Constant, 2004-2018 11

Figure 3: Diabetes Care Devices, North America, Overall Revenue ($m), USD Constant, Historic, 2004-2011 12

Figure 4: Diabetes Care Devices, North America, Overall Revenue ($m), USD Constant, Forecast, 2011-2018 14

Figure 5: Diabetes Care Devices, North America, Company share (%), 2011 16

Figure 6: Diabetes Care Devices, United States, Overall Revenue ($m), USD Constant, 2004-2018 18

Figure 7: Diabetes Care Devices, United States, Overall Revenue ($m), USD Constant, Historic, 2004-2011 19

Figure 8: Diabetes Care Devices, United States, Overall Revenue ($m), USD Constant, Forecast, 2011-2018 21

Figure 9: Diabetes Care Devices, United States, Company Share (%), 2011 24

Figure 10: Glucose Monitoring, United States, Company Share (%), 2011 26

Figure 11: Insulin Delivery, United States, Company Share (%), 2011 28

Figure 12: Diabetes Care Devices, Canada, Overall Revenue ($m), USD Constant, 2004-2018 30

Figure 13: Diabetes Care Devices, Canada, Overall Revenue ($m), USD Constant, Historic, 2004-2011 31

Figure 14: Diabetes Care Devices, Canada, Overall Revenue ($m), USD Constant, Forecast, 2011-2018 33

Figure 15: Diabetes Care Devices, Canada, Company Share (%), 2011 36

Figure 16: Glucose Monitoring, Canada, Company Share (%), 2011 38

Figure 17: Insulin Delivery, Canada, Company Share (%), 2011 40

Figure 18: LifeScan, Inc., Company Share (%), North America Diabetes Care Devices Market, 2011 42

Figure 19: Medtronic, Inc., Company Share (%), North America Diabetes Care Devices Market, 2011 43

Figure 20: Bayer HealthCare AG, Company Share (%), North America Diabetes Care Devices Market, 2011 44

Figure 21: F. Hoffmann-La Roche Ltd., Company Share (%), North America Diabetes Care Devices Market, 2011 45

Figure 22: Abbott Laboratories, Company Share (%), North America Diabetes Care Devices Market, 2011 46

Figure 23: Becton, Dickinson and Company, Company Share (%), North America Diabetes Care Devices Market, 2011 47

Companies mentioned

LifeScan, Inc.

Medtronic, Inc.

Bayer HealthCare AG

F. Hoffmann-La Roche Ltd.

Abbott Laboratories

Becton, Dickinson and Company

Eli Lilly and Company

Novo Nordisk A/S

Animas Corporation

Insulet Corporation

Sanofi

Nipro Corporation

ARKRAY, Inc.

To order this report:

Pathology Industry: North America Diabetes Care Devices Market Outlook to 2018 - Glucose Monitoring and Insulin Delivery

Contact Nicolas: nicolasbombourg@reportlinker.com
US: (805)-652-2626
Intl: +1 805-652-2626

SOURCE Reportlinker